| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―23 |
Unveiling the Role of SARS-CoV-2 or mRNA Vaccine Spike Protein in
Macrophage Activation Syndrome (MAS) |
Ziad Fajloun, Layla Tajer, Ziad Abi Khattar, Jean-Marc Sabatier |
| 2 |
[GO] |
2024―Jul―11 |
Emergence of COVID-19's JN.1 Subvariant Sparks Outbreak in India |
Raj kamal, OkesanyaOlalekan John, Raj Kumar Narang, Amandeep Singh |
| 3 |
[GO] |
2024―Jun―28 |
Exploring New COVID-19 Incertitude: JN.1 Variant- JN.1: The Queer Bird Among Omicron Sublineages |
Suman Kumar Ray, Sukhes Mukherjee |
| 4 |
[GO] |
2024―Jun―28 |
The Relationship between the Clinical Course of SARS-CoV-2 Infections and Expression of Bruton's Tyrosine Kinase |
Mitra Rezaei, Abdolreza Babamahmoodi, Alireza Mirahmadi, Niloufar Bineshfar, Shima Mahmoudi, Somayeh Ghadimi, Melika Valizadeh, Tannaz Malakouti, Fatemeh Talebian Taheri, Hadiseh Mohammadppour, Farinaz Nasr Azadani, Seyed Ali Ziai, Seyed Mohammad Poorhosseini, Majid Marjani |
| 5 |
[GO] |
2024―May―02 |
SARS-CoV-2 or Vaccinal Spike Protein can Induce Mast Cell Activation Syndrome (MCAS) |
Ziad Fajloun, Ziad Abi Khattar, Jean-Marc Sabatier |
| 6 |
[GO] |
2024―Apr―30 |
Renin-Angiotensin System Dysregulation: ADAM17 Activation Conse-quences Related to SARS-CoV-2 |
Julien Giacomoni, Jean-Marc Sabatier |
| 7 |
[GO] |
2024―Apr―22 |
Vitamin D and Mitochondrial Activity Preservation in COVID-19 |
Julien Giacomoni, Jean-Marc Sabatier |
| 8 |
[GO] |
2024―Apr―19 |
Recombinant ACE2 - Opportunities and Challenges in COVID-19 Treatment |
Rahul Sandhu, Mandeep Kaur, Akriti Aggarwal |
| 9 |
[GO] |
2024―Mar―11 |
The Intriguing Connection between Cholestasis and the Renin-Angiotensin System Dysregulation Induced by SARS-CoV-2 and/or the Vaccinal Spike Protein |
Ziad Fajloun, Ziad Abi Khattar, Jean-Marc Sabatier |
| 10 |
[GO] |
2024―Mar―06 |
Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence |
SeyedAhmad SeyedAlinaghi, Amir Masoud Afsahi, Pegah Mirzapour, Arian Afzalian, Ramin Shahidi, Mohsen Dashti, Afsaneh Ghasemzadeh, Parinaz Paranjkhoo, Zahra Parsaei, Ava Pashaei, Parsa Mohammadi, Mohammad Sadeq Najafi, Sona Mahrokhi, Parisa Matini, Ali Moradi, Amirali Karimi, Solaiman Afroughi, Esmaeil Mehraeen, Omid Dadras |
| 11 |
[GO] |
2024―Feb―12 |
Factors Associated with Mortality in Patients with Coronavirus Disease
(COVID-19) in Babol, North of Iran |
Mansour Babaei, Behzad Heidari, Hossein Ghorbani, Zahra Ahmadnia, Samaneh Rouhi, Mahmoud Sadeghi Haddad Zavareh |
| 12 |
[GO] |
2024―Feb―07 |
Can an International Student Group at TUMS in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of COVID-19 through Mentorship? |
Seyed Ahmad Seyed Alinaghi, Esmaeil Mehraeen |
| 13 |
[GO] |
2024―Feb―01 |
Estimating Hidden Population Size of COVID-19 Using Respondent-
Driven Sampling Method - A Systematic Review |
Seyed Ahmad Seyed Alinaghi, Arian Afzalian, Mohsen Dashti, Afsaneh Ghasemzadeh, Zohal Parmoon, Ramin Shahidi, Sanaz Varshochi, Ava Pashaei, Samaneh Mohammadi, Fatemeh Khajeh Akhtaran, Amirali Karimi, Khadijeh Nasiri, Esmaeil Mehraeen, Daniel Hackett |
| 14 |
[GO] |
2024―Jan―29 |
Two Birds with One Stone: Drug Regime Targets Viral Pathogenesis
Phases and COVID-19 ARDS at the Same Time |
Ghazaleh Ghavami, Soroush Sardari |
| 15 |
[GO] |
2024―Jan―23 |
A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in
2023 or far from Over |
Suman Kumar Ray, Sukhes Mukherjee |
| 16 |
[GO] |
2024―Jan―05 |
Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies |
Shahid Nawaz, Sara Juniad, Aiman Fatima, Maira Saleem, Urooj Fatima, Asad Ali |
| 17 |
[GO] |
2023―Dec―20 |
Can Waves of Autoimmune Diseases Occur after The COVID-19
Pandemic? |
SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Esmaeil Mehraeen |
| 18 |
[GO] |
2023―Nov―10 |
Triple Burden: The Incorrigible Threat of Tuberculosis, HIV, and
COVID-19 |
Parakriti Gupta, Diljot Sandhu, Varsha Gupta, Lipika Singhal |
| 19 |
[GO] |
2023―Nov―10 |
Can Vaccination with Various Types of Vaccines Make Communities
Safer against COVID-19? |
SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Esmaeil Mehraeen |
| 20 |
[GO] |
2023―Nov―01 |
Estimating the Size of the Hidden Population of COVID-19 |
Esmaeil Mehraeen, Fatemeh Khajeh Akhtaran, Mohammad Reza Faridrohani, Arian Afzalian, Hengameh Mojdeganlou, Zeinab Ghanbari, Yasamin Fathzadeh, Mohadeseh Gholizadeh, SeyedAhmad SeyedAlinaghi, Daniel Hackett |
| 21 |
[GO] |
2023―Aug―23 |
Emergence of Monkeypox (MPX): A Close Relative of Small Pox during Covid-19 Era |
Ivneet Kour, Lipika Singhal, Sonia Mehta, Varsha Gupta |
| 22 |
[GO] |
2023―Aug―16 |
Advancement of Computational Design Drug Delivery System in COVID-19: Current Updates and Future Crosstalk- A Critical update |
Abu Mohiuddin, Sumanta Mondal |
| 23 |
[GO] |
2023―Jun―23 |
Covid-19: Potassium Contributes to Pathologies That Cause Disability |
Jean-Marc Sabatier, Ziad Fajloun, Yingliang Wu, Zhijian Cao, Hervé Kovacic |
| 24 |
[GO] |
2023―Jun―21 |
Covid-19 and Parkinson's Disease: the Link also Established! |
Jean-Marc Sabatier, Ziad Fajloun, Yingliang Wu, Zhijian Cao, Hervé Kovacic |
| 25 |
[GO] |
2023―Jun―14 |
Time-to-survival from COVID-19 disease and its associated factors in Osun State, Nigeria |
Olowe Olugbenga, Adeagbo O, Olaitan Peter, Olowe Rita, Opakunle O, Eniade OD, Olarinmoye AT, Atolagbe James |
| 26 |
[GO] |
2023―Jun―01 |
Th17 overexpression in severe COVID-19: a prospective observational study |
Arvind Kumar, Ankesh Gupta, Rakesh Kumar Deepak, Umang Arora, Aayush Agrawal, Manish Soneja, Prerna Garg, Sanchit Kumar, Praveen Kumar, Uma Kanga, Ganesh Kumar V, Kapil Dev Soni, Naveet Wig |
| 27 |
[GO] |
2023―Jun―01 |
The Effectiveness of Face Masks in Preventing COVID-19 Transmission: A Systematic Review |
Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Amir Masoud Afsahi, Pegah Mirzapour, Sanaz Varshochi, Hengameh Mojdeganlou, Paniz Mojdeganlou, Armin Razi, Sanam Alilou, Mohsen Dashti, Afsaneh Ghasemzadeh, Solmaz Saeidi, Omid Dadras |
| 28 |
[GO] |
2023―May―31 |
COVID-19 and Alzheimer's Disease: The Link Finally Established |
Ziad Fajloun, Yingliang Wu, Zhijian Cao, Hervé Kovacic, Jean-Marc Sabatier |
| 29 |
[GO] |
2023―May―23 |
Does Widespread Use of Hydroxychloroquine Reduce the Transmissibility of SARS-CoV-2 / COVID-19? An Ecological Correlational Study |
Fabricio Souza Neves |
| 30 |
[GO] |
2023―May―17 |
Social avoidance and emotional deprivation of healthcare providers during the COVID-19 pandemic |
SeyedAhmad SeyedAlinaghi, Esmaeil Mehraeen, Parinaz Paranjkhoo, Daniel Hackett |
| 31 |
[GO] |
2023―May―11 |
COVID-19 and anti-COVID-19 vaccination: potential damages to the thyroid gland |
Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic |
| 32 |
[GO] |
2023―May―11 |
The use of remdesivir in patients with COVID-19 |
Soheil Ebrahimpour, Zeinab Mohseni Afshar, Dariush Hosseinzadeh, Rezvan Hosseinzadeh, Arefeh Babazadeh, Amirreza Allahgholipour, Terence T. Sio, Mark J. M. Sullman, Kristin Carson-Chahhoud, Mohammad Barary |
| 33 |
[GO] |
2023―May―04 |
Hemofiltration as an alternative for IL-6 inhibitors in COVID-19 cytokines storm associated with underlaying bacterial infections: A review Article |
Sherief M Abd-Elsalam, Samy Zaky, Mohamed El Badry, Hoda A Makhlouf, Tarik S. Sarhan, Noha H. Eltaweel, Heba Aly, Akram Abdelbary, Ahmed Said, Mohammed Hamdy Farouk, Amin Abdelbaki, Hanaa Fathelbab, Reham Hammad, Fathiya El-Raey |
| 34 |
[GO] |
2023―May―04 |
SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review |
Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Pegah Mirzapour, Roghayeh Salmani, Armin Razi, Hengameh Mojdeganlou, Paniz Mojdeganlou, Mohammad Qodrati, Reyhaneh Jashaninejad, Parinaz Paranjkhoo, Omid Dadras, Besharat Zarezadeh, Amir Masoud Afsahi, Arian Afzalian, Sanaz Varshochi, Ghazaleh Afsahi |
| 35 |
[GO] |
2023―Apr―18 |
Post-Exposure Prophylaxis for COVID-19: A Systematic Review |
Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Zahra Pashaei, Parnian Shobeiri, Nazanin Janfaza, Farzane Behnezhad, Afsaneh Ghasemzadeh, Alireza Barzegary, Ghazal Arjmand, Alireza Noroozi, Alireza Shojaei, Ava Amiri, Farzin Vahedi, Mehrdad Mahalleh, Ahmadreza Shamsabadi, Mohsen Dashti, Amir Masoud Afsahi, Omid Dadras |
| 36 |
[GO] |
2023―Apr―05 |
The Psychological, Philosophical, and Political Implications of COVID-19 |
Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Daniel Hackett |
| 37 |
[GO] |
2023―Mar―10 |
Role of Supplements in the Management of COVID-19 - A Comprehensive Review |
Rajkapoor Balasubramanian, Naina Mohamed Pakkir Maideen, Sudha Muthusamy, Sambathkumar Ramanathan, Mohamed Harsath Jahir Hussain |
| 38 |
[GO] |
2023―Mar―06 |
Biochemical, serological and immunological tests for diagnosis of coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis |
Reza Ranjbar, Milad Azami, Amirreza Jamshidbeigi, Hadi Esmaeili Gouvarchin Ghaleh |
| 39 |
[GO] |
2023―Mar―02 |
Can the new BA.2.75 sub-variant lead to one more COVID-19 wave? |
Sukhes Mukherjee, Suman Kumar Ray |
| 40 |
[GO] |
2023―Feb―28 |
Marburg Virus- A threat during SARS-CoV-2 era: A Review |
Sumel Ashique, Vatan Chaudhary, Soumen Pal, Jonee Panwar, Mukesh Kumar, Soumi Pramanik, Abhipsa Sinha, Anagh Mukherjee |
| 41 |
[GO] |
2023―Feb―27 |
Understanding and Relieving of Neuropathic Disorders in the Long COVID |
Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros |
| 42 |
[GO] |
2023―Feb―24 |
Anti-Covid-19 Vaccination, Covid-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-progestin Pill |
Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros |
| 43 |
[GO] |
2023―Feb―24 |
Potential of Black Seeds (Nigella Sativa) in the Management of Long
COVID or Post-acute Sequelae of COVID-19 (PASC) and Persistent
COVID-19 Symptoms - An Insight |
Naina Mohamed Pakkir Maideen, Abdurazak Hassan Jumale, Ibrahim Ramadan Barakat, Ayesha Khalifa Albasti |
| 44 |
[GO] |
2023―Feb―10 |
SIBO: the trail of a "new" human pathology associated with multiple severe and disabling Covid-19 and long Covid symptoms or induced by the anti-Covid-19 vaccine |
Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros |
| 45 |
[GO] |
2023―Jan―25 |
Estimating methods of the undetected infections in the COVID-19 outbreak: a systematic review |
SeyedAhmad SeyedAlinaghi, Esmaeil Mehraeen, Zahra Pashaei, Fatemeh Khajeh Akhtaran, Mohsen Dashti, Arian Afzalian, Afsaneh Ghasemzadeh, Pooria Asili, Mohammad Saeed Kahrizi, Maryam Mirahmad, Ensiyeh Rahimi, Parisa Matini, Amir Masoud Afsahi, Omid Dadras |
| 46 |
[GO] |
2023―Jan―23 |
The impact of COVID-19 pandemic on the levels of physical activity: A systematic review |
SeyedAhmad SeyedAlinaghi, Esmaeil Mehraeen, Amirali Karimi, Seyed Peyman Mirghaderi, Pegah Mirzapour, Zahra Pashaei, Kowsar Qaderi, Amir Masoud Afsahi, Alireza Barzegary, Parsa Mohammadi, Alireza Shojaei, Solmaz Saeidi, Fatemeh Afroughi, Mehrzad MohsseniPour, Nazanin Janfaza, Omid Dadras, Ava Amiri, Kimia Azad, Marcarious M. Tantuoyir, Fabricio Voltarelli |
| 47 |
[GO] |
2023―Jan―12 |
Why can high-level athletes develop very severe or fatal forms after intense exercise following SARS-CoV-2 infection or anti-Covid vaccination? |
Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros |
| 48 |
[GO] |
2023―Jan―05 |
COVID-19 and Ehlers-Danlos syndrome: the dangers of the Spike protein of SARS-CoV-2 |
Jean-Marc Sabatier, Ziad Fajloun, Christian Legros |
| 49 |
[GO] |
2022―Nov―02 |
Discharge of Confirmed COVID-19 Patients Based on WHO or Regional
Criteria? A Cohort Study |
Jamshid Vafaeimanesh, Seyed Hasan Adeli, Mahmoud Parham, Akram Asghari, Mohammad Bagherzade, Rasoul Shajari, Reihane Tabarraii, Masoumeh Shakeri, Amir Jabbari, Saeede Jafari, Sajjad Ahmadpour, Mohamad Amin Habibi, Javad Khodadai, Hamed Shafiee, Narges Eskandari, Davoud Olad Dameshghi, Maryam Masoumi, Seyed Yaser Foroghi Ghomi, Ali Ebrazeh |
| 50 |
[GO] |
2022―Oct―28 |
Interplay between SARS-CoV-2 and Cancer: Plausible Risk factors, Cellular Immune Responses, Cancer Directed Therapy- Current Challenges |
Sukhes Mukherjee, Suman Kumar Ray |
| 51 |
[GO] |
2022―Sep―03 |
COVID-19 Mass Vaccination and Flu season: Concern for Decreased Public Health Measures and worsening the influenza situation |
Shahab Falahi, Azra Kenarkoohi, Jasem Mohamadi, Iraj Pakzad, Hojjat Sayyadi |
| 52 |
[GO] |
2022―Sep―03 |
Molecular docking study of potential antimicrobial photodynamic therapy as a potent inhibitor of SARS-CoV-2 main protease: An in silico insight |
Abbas Bahador, Maryam Pourhajibagher |
| 53 |
[GO] |
2022―Aug―31 |
A New Year, Newfangled COVID-19 Variant B.1.640.2 (IHU): What We Know So Far? |
Sukhes Mukherjee, Suman Kumar Ray |
| 54 |
[GO] |
2022―Aug―19 |
Latest in COVID-19 Vaccine 'Candidates' Race |
Manar Fayiz Atoum, Dalia Abu Zreig, Laith M Abu Zreig |
| 55 |
[GO] |
2022―Jul―31 |
A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19) |
Suraj N. Mali |
| 56 |
[GO] |
2022―Jul―31 |
Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report. |
SeyedAhmad SeyedAlinaghi |
| 57 |
[GO] |
2022―Jul―31 |
Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review. |
Timotius Ivan Hariyanto |
| 58 |
[GO] |
2022―Jul―31 |
A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case |
Fereshteh Ghiasvand |
| 59 |
[GO] |
2022―Jul―31 |
Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients |
Cédric Annweiler |
| 60 |
[GO] |
2022―Jul―31 |
Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report |
Zahra Ahmadinejad |
| 61 |
[GO] |
2022―Jul―31 |
Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction. |
Nahid Akhtar |
| 62 |
[GO] |
2022―Jul―31 |
Transmission Modes of COVID-19: A Systematic Review. |
Esmaeil Mehraeen |
| 63 |
[GO] |
2022―Jul―31 |
Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital |
Fereshteh Ghiasvand |
| 64 |
[GO] |
2022―Jul―31 |
SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments |
Zhijian Cao |
| 65 |
[GO] |
2022―Jul―31 |
Chloroquine as Chemoprophylaxis for COVID-19: Will This Work. |
Sherief Abd-Elsalam |
| 66 |
[GO] |
2022―Jul―31 |
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases. |
Trinath Chowdhury |
| 67 |
[GO] |
2022―Jul―31 |
SARS-CoV-2: The Path of Prevention and Control |
Amal A. Mohamed |
| 68 |
[GO] |
2022―Jun―21 |
MMP3 in Severe COVID-19: A Biomarker or Therapeutic Target? |
Sultan Almuntashiri, Duo Zhang, Payaningal R. Somanath, Andrea Sikora |
| 69 |
[GO] |
2022―Jun―13 |
Postural orthostatic tachycardia syndrome and orthostatic hypotension post COVID-19 |
Masoud Eslami, Reza Mollazadeh, Shayan Mirshafiee, Parisa Sehat, Fatemeh Alizadeh, Zahra Emkanjoo, Vahideh Laleh far, Elnaz Shahmohamadi |
| 70 |
[GO] |
2022―Jun―07 |
Divulging Incipient SARS-CoV-2 Delta (B.1.617.2) Variant: Possible Interference with Global Scenario |
Suman Kumar Ray, Sukhes Mukherjee |
| 71 |
[GO] |
2022―May―31 |
COVID-19 Associated Acute Pancreatitis: A Case Series from India |
Jitendra Singh, Nilesh Kumar, Kailash Kumar, Anju Dinkar |
| 72 |
[GO] |
2022―May―27 |
Epidemiological study of COVID-19 in Iran and the world: a review study |
Nasges Ansari, Samira Shokri, Mohadeseh Pirhadi, Saber Abbaszadeh, Aliasghar Manouchehri |
| 73 |
[GO] |
2022―Apr―29 |
Demographic, clinical, investigational characteristics of COVID-19 related Guillain-Barré syndrome with differences from typical and another virus-related Guillain-Barré syndrome |
Jitendra Singh, Nilesh Kumar, Anju Dinkar |
| 74 |
[GO] |
2022―Apr―26 |
‘Convalescent Plasma’- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review |
Sumel Ashique, Tahamina Khatun, Garima Sahu, Aakash Upadhyay, Archana Adhana, Nitish Kumar, Shubneesh Kumar, Navjot Sandhu |
| 75 |
[GO] |
2022―Apr―25 |
Infection and Severity of COVID-19 infection among health care workers: A report from Egypt |
Ehab F Moustafa, Sahar M Hassany, Asmaa Mohamed Ahmed Soliman, Mohammed Ezz-Eldin, Nariman Zaghloul, Sherief Abd-Elsalam |
| 76 |
[GO] |
2022―Apr―25 |
The emergence of Omicron SARS-CoV-2 variant (B.1.1.529) - the latest episode in the COVID-19 pandemic with a global riposte |
Suman Kumar Ray, Sukhes Mukherjee |
| 77 |
[GO] |
2022―Apr―22 |
Epigenetic-related effects of COVID-19 on the human cells |
Arezoo Faramarzi, Reza Safaralizadeh, Narges Dastmalchi, Shahram Teimourian |
| 78 |
[GO] |
2022―Apr―20 |
A clinically validated, broadly active, oral viral superinfection therapy could mitigate symptoms in early-stage COVID-19 patients |
Tibor Bakacs, Volker Sandig, Shimon Slavin, Serhat Gumrukcu, W David Hardy, Wolfgang Renz, Imre Kovesdi |
| 79 |
[GO] |
2022―Apr―20 |
Prevalence, presentation and outcome of secondary bloodstream infections among the COVID-19 patients |
Subhashree Samantaray, Priyabrat Karan, Anuradha Sharma, Vijayalakshmi Nag, Naveen Dutt, Mahendra Kumar Garg, Pradeep Kumar Bhatia, Sanjeev Misra |
| 80 |
[GO] |
2022―Apr―20 |
COVID-19 vaccination, Peltzman Effect and possible increase in high-risk behaviors: a growing concern on risk compensation and reduced compliance to Public Health protective Measures after vaccines rollout |
Shahab Falahi, Jasem Mohamadi, Hojjat Sayyadi, Iraj Pakzad, Ayoub Rashidi, Razi Naserifar, Jahangir Abdi, Azra Kenarkoohi |
| 81 |
[GO] |
2022―Apr―07 |
COVID-19 and Co-infections: A Serious Health Threat Requires Combination Diagnosis and Therapy |
Shahid Nawaz, Maira Saleem |
| 82 |
[GO] |
2022―Apr―07 |
SARS-CoV-2-Induced Neurological Disorders in Symptomatic Covid-19 and Long Covid Patients: Key Role of Brain Renin-Angiotensin System |
Ziad Fajloun, Hervé Kovacic, Cédric Annweiler, Yingliang Wu, Zhijian Cao, Jean-Marc Sabatier |
| 83 |
[GO] |
2022―Apr―03 |
A new wave of COVID-19 in 2021 with unique genetic characters -present global scenario and beholding onwards |
Sukhes Mukherjee, Suman Kumar Ray |
| 84 |
[GO] |
2022―Mar―25 |
Technology in the Era of COVID-19: A Systematic Review of Current Evidence |
Esmaeil Mehraeen, Mohammad Mehrtak, SeyedAhmad SeyedAlinaghi, Zahra Nazeri, Amir Masoud Afsahi, Farzane Behnezhad, Farzin Vahedi, Alireza Barzegary, Amirali Karimi, Nahid Mehrabi, Omid Dadras, Shayesteh Jahanfar |
| 85 |
[GO] |
2022―Mar―23 |
Therapeutic strategies for COVID-19 patients: An update |
Muhammad Ibrahim Getso, So�h Etemadi, Vahid Raissi, Moein Mohseni, Maedeh Sadat Mohseni, Farid Raeisi, Omid Raiesi |
| 86 |
[GO] |
2022―Mar―22 |
An update review on complicated mechanisms of COVID-19 pathogenesis and therapy: direct viral damage, renin-angiotensin system dysregulation, immune system derangements, and endothelial dysfunction |
Shahab Falahi, Maryam Maleki, Azra Kenarkoohi |
| 87 |
[GO] |
2022―Mar―22 |
An Insight of Clinical Evidences of Ayurveda Interventions in the Management of COVID-19 Patients |
Naina Mohamed Pakkir Maideen, Rajkapoor Balasubramaniam, Gobinath Manavalan, Kumar Balasubramanian, Vasanth Kumar S |
| 88 |
[GO] |
2022―Mar―18 |
DO METHYLENE BLUE SATISFIES AN OPTION - IN COVID-19 ARDS |
Sri Hari TY, Sree Sudha TY, Krishna Sasanka KSBS, Pugazhenthan Thangaraju |
| 89 |
[GO] |
2022―Mar―18 |
Original antigenic sin in COVID-19: Hoskins effect and vaccine |
Mudassir Khan, Sobia Manzoor, Najeeb Ullah, Dilawar Khan |
| 90 |
[GO] |
2022―Feb―25 |
The Persistence Time of SARS-CoV-2 RNA in hospitalized COVID-19 Patients: A prospective Study |
Jila Yavarian, Mohammad Javaherian, Somayeh Shatizadeh Malekshahi, Zahra Ahmadinejad, Fatemeh Ghiasvand, Elaheh Ahmadi, Ladan Abbasian, Malihe Hasannezhad Malihe Hasannezhad, Narges Dabaghipour, Nazanin-Zahra Shafiei-Jandaghi, Talat Mokhtari-azad, Mahboubeh Hajiabdolbaghi |
| 91 |
[GO] |
2022―Feb―22 |
Impact of tocilizumab on inflammatory markers and oxygen status in severe covid-19 patients: A single centre retrospective study. |
Abhishek Sharma, Deepak Nathiya, Supriya Suman, Hemant Bareth, Mahaveer Singh, Eshan Sharma |
| 92 |
[GO] |
2022―Feb―21 |
A Review on the New Indication of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in the Treatment of Coronavirus Disease 2019 |
Hedyieh Karbasforooshan, Sofia Salari, Hesamoddin Hosseinjani |
| 93 |
[GO] |
2022―Feb―16 |
Covid-19 Study, Pathology and Therapeutics |
Da-Yong Lu |
| 94 |
[GO] |
2022―Feb―09 |
Third waves of the COVID-19 pandemic: Prominence of initial public health Interference |
Sukhes Mukherjee, Suman Kumar Ray |
| 95 |
[GO] |
2022―Jan―28 |
Gallium Components-Based Drug Delivery: A Potential Treatment for COVID-19 |
Sara Torabi, Farbod Bahreini, Nima Rezaei |
| 96 |
[GO] |
2022―Jan―28 |
A case of multiple sclerosis with protracted course of COVID-19 |
Mehrdad Hasibi, Marjan Asadollahi, Ali Asadollahi-Amin |
| 97 |
[GO] |
2022―Jan―28 |
Diagnostic Stewardship in Times of Covid-19 Pandemic |
Lipika Singhal, Ivneet Kour, Varsha Gupta |
| 98 |
[GO] |
2022―Jan―24 |
An Overview of Antiviral Properties of Bacteriophages with Emphasis on the Treatment of COVID-19 Infection |
Mahsa Jalili, Nastaran Ansari, Behzad Pourhossein, Maryam Fazeli, Farid Azizi Jalilian |
| 99 |
[GO] |
2022―Jan―20 |
Molecular docking of phytochemical compounds of Momordica charantia as potential inhibitor against SARS-CoV-2 |
Yayu Mulsiani Evary, Ayu Masyita, Arie Ariezandi Kurnianto, Rangga Meidianto Asri, Yusnita Rifai |
| 100 |
[GO] |
2022―Jan―19 |
Ivermectin in COVID-19 Management: What is the current evidence? |
Madhavi Eerike, Gerard Marshall Raj, Rekha Priyadarshini, Gandham Ravi, Debasis Bisoi, Venu Gopala Rao Konda |
| 101 |
[GO] |
2022―Jan―18 |
Procalcitonin as a prognostic factor in patients with COVID-19 in southwestern Iran |
Milad Shahini Shams Abadi, Elham Taheri, Ahmad Raesi, Mohammad-Hassan Arjmand, Soleiman Kheirii, Najmeh Shahinfard, Zahra Habibi |
| 102 |
[GO] |
2022―Jan―18 |
Therapeutic Status of Famotidine in COVID-19 Patients: A Review |
Moein Mohseni, Vahid Raissi, Yasamin Sharifan, Kimia Barikro, Sasan Amiri, Maedeh Sadat Mohseni, Farid Raeisi, Kimia Masoumi, Sina Khodakarami, Omid Raiesi |
| 103 |
[GO] |
2022―Jan―18 |
Challenges in Engendering Herd Immunity to SARS-CoV-2 infection: Possibly Impossible but Plausibility with Hope |
Sukhes Mukherjee, Suman Kumar Ray |
| 104 |
[GO] |
2022―Jan―06 |
COVID-19 Infection in Pregnancy: A Review |
Sabrina Jahan Mily, Kazi Mahmuda Akter, Nowshin Jabin, Saikat Mitra, Talha Bin Emran, Monisha Nandi, Sumit Kumar Baral, Md. Zia Uddin, Jewel Mallick, Arkajyoti Paul, Syed Uzair Ali Shah, Abdur Rauf, Ishaq N. Khan, Mohammad S. Mubarak |
| 105 |
[GO] |
2022―Jan―06 |
The chance of COVID-19 infection after vaccination |
Ghazaleh Khalili-Tanha, Majid Khazaei, Saman Soleimanpour, Gordon A Ferns, Amir Avan |
| 106 |
[GO] |
2021―Dec―02 |
Case Report: Severe SARS-CoV-2 Infection with Remdesivir in a Patient with ESRD |
Raj H. Patel, Pablo M. Pella, Naeem Haider, Renato Blanco |
| 107 |
[GO] |
2021―Sep―30 |
COVID-19 in pediatrics: The current knowledge and practice |
Esmaeil Mehraeen, Shahram Oliaei, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Pegah Mirzapour, Amir Masoud Afsahi, Alireza Barzegary, Farzin Vahedi, Mahdi Soleymanzadeh, Farzane Behnezhad, Mohammad Javaherian, Ghazal Zargari, Seyed Peyman Mirghaderi, Tayebeh Noori, Jean-Marc Sabatier |
| 108 |
[GO] |
2021―Sep―23 |
Vaccines for COVID-19: A Review of Feasibility and Effectiveness |
Esmaeil Mehraeen, Omid Dadras, Amir Masoud Afsahi, Amirali Karimi, Mehrzad MohsseniPour, Pegah Mirzapour, Alireza Barzegary, Farzane Behnezhad, Pedram Habibi, Mohammad Amin Salehi, Farzin Vahedi, Mohammad Heydari, Shaghayegh Kianzad, Banafsheh Moradmand-Badie, Mohammad Javaherian, SeyedAhmad SeyedAlinaghi, Jean-Marc Sabatier |
| 109 |
[GO] |
2021―Sep―16 |
Liver injury in COVID-19: A Direct hit or Collateral damage? |
Balasubramaniyan Vairappan, Gavin Wright, Douglas Corrigal |
| 110 |
[GO] |
2021―Sep―13 |
Counter-Regulatory Renin-Angiotensin System: An Important Line of Research to Understand and Limit the Severity of COVID-19 |
Cédric Annweiler, Zhijian Cao, Nicolas Papon, Hervé Kovacic, Jean-Marc Sabatier |
| 111 |
[GO] |
2021―Sep―07 |
Persistent Hiccups as an Atypical Initial Presentation of COVID-19: A Case Report |
Omid Dadras, Alimohamad Asghari, Atefe Nosratzahi |
| 112 |
[GO] |
2021―Sep―06 |
SARS-CoV-2 transmission among health care workers in Iran: an urgent need for early identification and management |
Mohammad Reza Abdolsalehi, Shima Mahmoudi, Reza Shervin Badv, Babak Pourakbari, Keyvan Mirnia, Yasmine Mahmoudieh, Setareh Mamishi |
| 113 |
[GO] |
2021―Aug―30 |
DAMPening Severe COVID-19 with Dexamethasone |
Cédric Annweiler, Nicolas Papon, Jean-Marc Sabatier, Jean Barré |
| 114 |
[GO] |
2021―Aug―11 |
Can Antimalarial Phytochemicals be a Possible Cure for COVID-19? Molecular Docking Studies of Some Phytochemicals to SARS-CoV-2 3C-like Protease |
Anamul Hasan, Khoshnur Jannat, Tohmina Afroze Bondhon, Rownak Jahan, Md Shahadat Hossan, Maria de Lourdes Pereira, Veeranoot Nissapatorn, Christophe Wiart, Mohammed Rahmatullah |
| 115 |
[GO] |
2021―Jul―27 |
Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review |
Esmaeil Mehraeen, Zeinab Najafi, Bagher Hayati, Mohammad Javaherian, Sajad Rahimi, Omid Dadras, SeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Jean-Marc Sabatier |
| 116 |
[GO] |
2021―Jul―25 |
Genetics and Vaccine development for SARS-CoV2 in the era of Personalized Medicine |
Eirini Konstantina Tafanidou, Despoina Gkentzi |
| 117 |
[GO] |
2021―Jul―19 |
Shared Food, Meals and Drinks: 10 Arguments Suggesting an Oral Transmission Route of SARS-CoV-2 |
Jean-Michel Wendling, Aure Saulnier, Jean-Marc Sabatier |
| 118 |
[GO] |
2021―Jun―16 |
Hypothesis: Designation of Liposomal Scavenger System for Fighting against 2019-nCoV |
Nooshin Bagherani, Bruce R. Smoller |
| 119 |
[GO] |
2021―May―28 |
A short review on key role of plants and their extracts in boosting up immune response to combat COVID-19 |
Mudassir Khan, Muhammad Abu Bakar Saddique, Huzaifa Tahir, Muhammad Dawood Amjad, Abdullah Ahmad, Usama Masood, Dilawar Khan |
| 120 |
[GO] |
2021―Mar―23 |
Investigation of structural, treatment and clinical characteristics of COVID-19 along with the challenges caused by its prevalence |
Maham Doagooyan, Seyedeh Hoda Alavizadeh, Javad Akhtari, Amirhossein Sahebkar, Saeed Ghanbari Hasan Kiade, Pariya Haghgoo Kochesfahani, Fatemeh Gheybi |
| 121 |
[GO] |
2021―Mar―03 |
COVID-19 and Infectious Disease Speciality - A necessity of Time in India. |
Gopal K Bohra, Deepak Kumar, Mahendra K Garg |
| 122 |
[GO] |
2021―Mar―03 |
The recovery of an elderly woman with asthma and diabetes from COVID-19 infection: a case report |
Abas Ghaysouri, Maryam Safari, Elham Mohammadyari, Firooz Balavandi, Ali Nazari, Jalil Feizi, Mohamad Karimian, Elham Bastani, Ebrahim Salimi, Hamed Tavan |
| 123 |
[GO] |
2021―Mar―01 |
A mini review on the pathogenesis, diagnosis and treatment options for COVID-19 |
Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, Gordon A Ferns, Majid Khazaei, Soodabeh Shahidsales, Amir Avan |
| 124 |
[GO] |
2021―Mar―01 |
COVID-19: Potential Repurposing Drugs |
Wattana Leowattana |
| 125 |
[GO] |
2021―Feb―19 |
COVID-19 and Neurology - An Emerging Association |
Amit Gupta, Prakrati Yadav, Deepak Kumar |
| 126 |
[GO] |
2021―Feb―19 |
Natural Derived Nasal Spray; a Proposed Approach for COVID-19 Disease Control |
Zahra Hoseini-Tavassol, Hanieh-Sadat Ejtahed, Ahmad-Reza Soroush, Zahra Sajjadpour, Shirin Hasani-Ranjbar, Bagher Larijani |
| 127 |
[GO] |
2021―Feb―19 |
Hepatic involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran |
Ahmad Hormati, Mohammad Reza Ghadir, Mohammad Saeidi, Reza Aminnejad, Mahboubeh Afifian, Sajjad Ahmadpour |
| 128 |
[GO] |
2021―Feb―04 |
COVID-19 and Alcohol Misuse: A Case Report |
Ali Asadollahi-Amin, Ali Nowroozi, Mehrdad Hasibi, Behzad Asanjarani, SeyedAhmad SeyedAlinaghi |
| 129 |
[GO] |
2021―Feb―04 |
Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a patient with Hodgkin's lymphoma history from north of Iran |
David Darvishnia, Mahdieh Sadeghi, Ali Sharifpour, Zakaria Zakariaei, Elham Sadat Banimostafavi, Mahdi Fakhar, Rabeeh Tabaripour |
| 130 |
[GO] |
2021―Jan―19 |
The Role of Justicia Adhatoda as prophylaxis for COVID-19 - Analysis based on docking study |
Pugazhenthan Thangaraju, Sree Sudha TY, Praveen Kumar Pasala, Sri Hari TY, Sajitha Venkatesan, Eswaran Thangaraju |
| 131 |
[GO] |
2021―Jan―05 |
SARS-CoV-2: An insight into detection tools |
Shaghayegh Khanmohammadi, Mohammadreza Tabary, Farnaz Araghi, Seyed Mohammad Tavangar |
| 132 |
[GO] |
2021―Jan―05 |
Modifications of Medical Care of Chronic Liver Diseases during COVID19 Pandemic: Necessity or Novelty? |
Hanan Hamed Soliman, Mohamed H. Emara, Mahmoud Elkadeem, Sherief Abd-Elsalam |
| 133 |
[GO] |
2021―Jan―04 |
An Updated Review on COVID-19 |
Mahmoud Ahmed Ebada, Ahmed Wadaa Allah, Eshak Bahbah, Ahmed Negida |
| 134 |
[GO] |
2020―Dec―21 |
Pharmacological strategies for COVID-19 - A review of the most promising repurposed antiviral drugs. |
Deepti Chopra, Jaspreet K Boparai, Bharti Bhandari, Anurag Srivastava, Rakesh Gupta |
| 135 |
[GO] |
2020―Dec―21 |
Possible therapeutic interventions in COVID-19 induced ARDS by cotinine as an ACE-2 promoter and AT-1R blocker |
Tarun Sharma, Sidharth Mehan |
| 136 |
[GO] |
2020―Dec―10 |
Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report |
SeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Mehrnaz Asadi Gharabaghi, Fereshteh Ghiasvand |
| 137 |
[GO] |
2020―Dec―10 |
Coronavirus Disease 2019: Virology and Drug Targets |
Praveen Thaggikuppe Krishnamurthy |
| 138 |
[GO] |
2020―Dec―08 |
Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 through a Molecular Docking Study |
Milon Mondal, Chandan Sarkar, Sarmin Jamaddar, Abul Bashar Ripon Khalipha, Muhammad Torequl Islam, Azmi Mahafzah, Mohammad S. Mubarak |
| 139 |
[GO] |
2020―Nov―27 |
COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases |
Fereshteh Ghiasvand, Maryam Ghadimi, Sara Sadr, Fatemeh Jafari, Navid Manafi, Zahra Ah-madinejad, Samaneh Tirgar, Seyed Ahmad Seyed Alinaghi |
| 140 |
[GO] |
2020―Nov―17 |
Pharmacological inhibition of MMP3 as a potential therapeutic option for COVID-19 associated acute respiratory distress syndrome |
Rana Kadry, Andrea Sikora Newsome, Payaningal R. Somanath |
| 141 |
[GO] |
2020―Nov―17 |
A Patient with COVID-19 Pneumonia Presenting with Plural Effusion: A Case Report. |
Fereshteh Ghiasvand, SeyedAhmad SeyedAlinaghi, Samaneh Tirgar, Mohamad Reza Salehi, Banafsheh Moradmand-Badie |
| 142 |
[GO] |
2020―Nov―17 |
Transmission Modes of COVID-19: A Systematic Review |
Esmaeil Mehraeen, Mohammad Amin Salehi, Farzane Behnezhad, Hamed Rezakhani Moghaddam, SeyedAhmad SeyedAlinaghi |
| 143 |
[GO] |
2020―Nov―13 |
Postoperative COVID-19 pneumonia in an asymptomatic patient: a case report |
Ali Asadollahi-Amin, Elnaz Shahmohamadi, Mehrdad Hasibi, Maryam Moosivand, Maryam Taghizadeh, Seyed Ahmad Seyed Alinaghi |
| 144 |
[GO] |
2020―Nov―10 |
An overview on COVID-19 pandemic: from discovery to treatment |
Kalpana Panati, Venkatramana Reddy Arva Tatireddygari, Venkata Ramireddy Narala |
| 145 |
[GO] |
2020―Oct―30 |
Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review |
Timotius Ivan Hariyanto, Elizabeth Kristine, Catherine Jillian Hardi, Andree Kurniawan |
| 146 |
[GO] |
2020―Oct―20 |
A Viewpoint On Potential Biomarkers For Infectious COVID-19 severity: An Updated Literature Survey |
Suraj N. Mali, Fatemeh Mohajer, Ghodsi Mohammadi Ziarani, Amit P. Pratap |
| 147 |
[GO] |
2020―Oct―18 |
BCG vaccine, a ray of hope in treating Severe Acute Respiratory Syndrome (SARS) |
Amit Bandyopadhyay Banerjee, Thakur Gurjeet Singh, Abhimanyu Prashar |
| 148 |
[GO] |
2020―Oct―14 |
COVID-19 And Type 2 Diabetes Mellitus: Hydroxychloroquine May Be The Holy Grail |
Rimesh Pal, Manoj K. Bhasin, Sanjay K. Bhadada |
| 149 |
[GO] |
2020―Oct―07 |
Covid-19, SARS -CoV-2, Origin, transmission and treatment aspects, a brief review |
Shahid Nawaz |
| 150 |
[GO] |
2020―Sep―22 |
Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction |
Nahid Akhtar, Amit Joshi, Bhupender Singh, Vikas Kaushik |
| 151 |
[GO] |
2020―Sep―05 |
Impact of COVID-19 on Indian Pharmaceutical Industry and WayForward |
Nikita Vijay Jadhav, Nisha Singh, Monika Targhotra, Meenakshi K. Chauhan |
| 152 |
[GO] |
2020―Aug―05 |
Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein |
Bipin Singh |
| 153 |
[GO] |
2020―Jul―30 |
Ocular COVID-19: Eyes as a reservoir to conceal and spread SARS-CoV-2 |
Abdul Mannan Baig, Saara Ahmad, Areeba Khaleeq, Hamna Rafique, Shafiqa Rajput, Mehaer Angez, Ayesha Hameed, Talha Nawaz, Preet Katyara |
| 154 |
[GO] |
2020―Jul―28 |
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases |
Trinath Chowdhury, Gourisankar Roymahapatra, Santi M. Mandal |
| 155 |
[GO] |
2020―Jul―27 |
Chloroquine as chemoprophylaxis for COVID-19: Will this work? |
Sherief Abd-Elsalam, Mahmoud Elkadeem, Khadija Ahmed Glal |
| 156 |
[GO] |
2020―Jul―21 |
Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis. |
Tommy Richard Sun-Wing TONG |
| 157 |
[GO] |
2020―Jun―22 |
Targeting infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) applications: Evidence based opinion |
Suraj N. Mali, Amit P. Pratap |
| 158 |
[GO] |
2020―Jun―09 |
Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report |
Zahra Ahmadinejad, Faeze Salahshour, Omid Dadras, Hesan Rezaei, SyyedAhmad Alinaghi |
| 159 |
[GO] |
2020―May―21 |
Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital |
Fereshteh Ghiasvand, SeyedAhmad SeyedAlinaghi |
| 160 |
[GO] |
2020―May―20 |
SARS-CoV-2: The Path of Prevention and Control |
Amal A. Mohamed, Nouran Mohamed, Seham Mohamoud, Fawkia E. Zahran, Rania Abdelmonem Khattab, Dalia Ali El-Damasy, Eman Alsayed, Sherief Abd-Elsalam |
| 161 |
[GO] |
2020―May―18 |
Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients |
Cédric Annweiler, Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Stéphanie Mouhat, Hervé Kovacic, Jean-Marc Sabatier |
| 162 |
[GO] |
2020―May―11 |
A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19) |
Suraj N. Mali, Bapu R. Thorat, Atul R. Chopade |
| 163 |
[GO] |
2020―May―06 |
SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments |
Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Jean-Marc Sabatier |
| 164 |
[GO] |
2020―Apr―29 |
A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case |
Fereshteh Ghiasvand, Sepideh Zahak Miandoab, Hamid Harandi, Fereshteh Shahmari Golestan, Seyed Ahmad Seyed Alinaghi |
